Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology

NEXT STORY
Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
PREV STORY
AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global R&D and Business Tracker for Bispecific Antibodies: 1 Year Subscription

Dublin, Aug. 16, 2017 (GLOBE NEWSWIRE) -- The "R&D and Business Tracker for Bispecific ...

author_avatar
NASDAQ Market News

Cempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016

CHAPEL HILL, N.C., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

author_avatar
NASDAQ Market News

Gluco Shield Pro Reviews – Negative Side Effects or Legit Ingredients?

author_avatar
NASDAQ Market News